MEDIA CENTRE    |    PRINT    |     FRANÇAIS
   

Welcome to the Lady Davis Institute
 
The Lady Davis Institute (LDI) is the research arm of Montreal's Jewish General Hospital, a teaching hospital of McGill University.
 
Founded in 1969, the LDI is one of Canada's leading health research institutes. Important discoveries which have contributed to the health and well-being of patients in Quebec, Canada, and around the world, have been made by LDI researchers in the areas of HIV/AIDS, aging, cancer, vascular disease, epidemiology, and psychosocial science. There are currently more than 117 full-time researchers at the LDI, of whom 70 are primarily lab-based, 21 investigate psychosocial aspects of disease, 26 are in epidemiology. In addition, there are 124 associate investigators. 
 
 

 
Pharma and Biotech:
Collaborate with the LDI
 
 
 
 
                         
 
News from the LDI
 
26/01/2017
Study concludes that androgen deprivation therapy is not associated with increased risk of Alzheimer disease in patients with prostate cancer
Researchers at the Lady Davis Institute have concluded that methodological issues were responsible for an earlier study’s controversial finding that a common treatment for late stage prostate cancer was associated with Alzheimer disease and other forms of dementia. Their more robust work has concluded that no such association exists.

 more...

09/01/2017
Association between certain antidepressants and the risk of intracranial bleeding
An investigation conducted at the Lady Davis Institute has shown that one of the effects of a particular type of antidepressant is to increase the risk of spontaneous intracranial hemorrhage.

 more...



Copyright © 2010 Lady Davis Institute/Jewish General Hospital.
Created by Blue Lemon Media Inc.
Sitemap | Disclaimer